Skip to main contentAI and Advanced
/
SHREEGANES · BSEBSE SENSEX77,656.09+0.37%BSE |
NIFTY 5024,334.55+0.48%NSE |
NIFTY BANK57,514.2-0.02%NSE |
NIFTY IT30,771.8+0.57%NSE |
NIFTY AUTO29,216.9+0.40%NSE |
NIFTY FMCG47,706.95+0.38%NSE |
NIFTY PHARMA26,564+0.85%NSE |
NIFTY 50023,611.6+0.42%NSE |
SH
BSE · Equity shares · Biotechnology-0.01 · -1.96%
Shree Ganesh Biotech (India) Ltd SHREEGANES
NSE:Not available
BSE:INR 0.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for SHREEGANES
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 0.51
Day rangeINR 0.5 — INR 0.52
52-week rangeINR 0.5 — INR 0.57
Volume11.66 L
Market cap19.93
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1.43
Net Income (INR Cr)-0.57
EPS-0.01
Research path: Interpret Shree Ganesh Biotech (India) Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SHREEGANESShree Ganesh Biotech (India) Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Jun-26 | Mar-26 | FY25-26 |
|---|---|---|---|
| Revenue | 1.43 | 2.12 | 4.97 |
| Net Profit | -0.57 | -0.15 | 0.38 |
| EPS | -0.01 | Not available | 0.01 |
| Cash EPS | -0.01 | Not available | 0.01 |
| OPM % | -40.07 | -6.98 | 10.36 |
| NPM % | -40.07 | -7.02 | 7.6 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m-40.07
Net Profit Margin 12m-40.07
Valuation
Price to Sale Ratio13.94
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 0.00%
- Public shareholders
- 100.00%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015BSE corporate filing · 4 Aug 2026, 5:30 am
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")BSE corporate filing · 4 Aug 2026, 5:30 am
Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026.BSE corporate filing · 4 Aug 2026, 5:30 am
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.BSE corporate filing · 21 Jul 2026, 5:30 am
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE corporate filing · 7 Jul 2026, 5:30 am
Closure of Trading WindowBSE corporate filing · 12 Jun 2026, 5:30 am
Corporate actions
Events
- board MeetingsGeneral
- board MeetingsResults
- corporate ActionsBonus issue 1:1
- board MeetingsGeneral
- board MeetingsResults
- board MeetingsGeneral
- board MeetingsResults
- corporate ActionsStock Split From Rs.10/- to Rs.1/-
ShareKeyX Community
Discussion and sentiment for Shree Ganesh Biotech (India) Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Biotechnology
- Sector
- Healthcare
- Website
- www.shreeganeshbiotech.shop
- Address
- 126,3/2, 75C, Park Street, 3rd Floor, Kamdhenu Building, Kolkata, West Bengal, 700016
- NSE Code
- SHREEGANES
- BSE Code
- 539470
- Listing date
- 24 Nov 2015
- Face value
- 1
- Market lot
- 1
- CIN
- L70101WB1982PLC121196
- Company email
- shreeganeshbiotechindialtd@gmail.com
- Company phone
- 033-23988213
Leadership and officers
- Executive Director-Chairperson
- Mr. AMAN PRAVINKUMAR PATEL
- Non-Executive - Independent Director
- Mr. SOMBIR SINGH
- Executive Director
- Mr. KISHAN NITYANAND NAIDU
- Non-Executive - Independent Director
- Mr. NIMESHKUMAR MOHANBHAI PARMAR
- Non-Executive - Independent Director
- Ms. AMRUTABEN RAJANBHAI SOLANKI
- Non-Executive - Independent Director
- Mr. HARSHADKUMAR RATHOD
- Company Secretary and Compliance Officer
- Ms. Namita Acharya
Questions
Stock FAQ
What is the symbol and ISIN of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has the symbol SHREEGANES and ISIN - INE051N01026.
What is the current price of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd is currently trading at INR 0.50.
What are the year high and year low of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a year high of INR 0.57 and a year low of INR 0.50.
What is the market capitalization of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a market capitalization of INR 19.93 crore.
What is the P/E ratio of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a P/E ratio of NA.
What is the dividend yield of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a dividend yield of NA.
How is the financial performance of Shree Ganesh Biotech (India) Ltd based on revenue, net income, and EPS?
Shree Ganesh Biotech (India) Ltd has revenue of INR 1.43 crore, net income of INR -0.57 crore, and EPS of NA.
What is the book value of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a book value of NA.
What is the debt-to-equity ratio of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Shree Ganesh Biotech (India) Ltd?
Shree Ganesh Biotech (India) Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 13.94.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.